Antithrombin Market Size, Share, Growth Report 2032

Antithrombin Market

Antithrombin Market by Source (Human and Goat Milk), Application (Diagnostics, Therapeutics, and Research), By Dosage Form (Liquid and Lyophilized): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028.

Category: Pharmaceutical Report Format : PDF Pages: 132 Report Code: ZMR-2514 Published Date: May-2021 Status : Published

The global Antithrombin market accounted for USD 543.0 Million in 2020 and is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.

Market Overview    

The global Antithrombin market accounted for USD 543.0 Million in 2020 and is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% from 2021 to 2028.     

Antithrombin is a protein present in the blood stream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to clot more easily. Vice-versa, if antithrombin levels are too high, a person could, theoretically, have a more bleeding tendency. However, raised levels of antithrombin do not appear to cause bleeding or have any clinical significance.

Antithrombin is a serpin which is similar in structure to most other plasma protease inhibitors. According to the report published by U.S. Department of health & human services in 2018, Antithrombin deficiency is expected to occur in about 1 in 2000 people across the globe.

Request Free Sample

COVID-19 Impact Analysis:

The Covid-19 has positively impacted on the growth of the Antithrombin market. As the Antithrombin is a protein which helps to regulate blood clot formation. Due to corona virus spread in the community, the protein level and immunity of the people drop due to severe attack of virus. In order to increase the protein level, the Antithrombin plays important role prevention of blood clotting as it acts as a natural blood thinner and extensively used while performing surgical procedures in the patient with low antithrombic levels. However, the world markets are slowly opening to their full potential and theirs a surge in demand of Antithrombin is likely to increase in the coming years. The market would remain bullish in upcoming year.   

Growth Factors

The widespread use of antithrombin for the treatment of various medical conditions such as extracorporeal membrane oxygenation, hereditary antithrombin deficiency, sepsis, and disseminated intravascular coagulation are the major factors responsible for the growth of global antithrombin market. Moreover, the rising adoption of antithrombin as a combination therapy with heparin is expected to open huge growth opportunities for antithrombin market.

Report Scope: 

Request Free Sample

Source Segment Analysis Preview

By source, the antithrombin market has been segmented as human, and goat milk. The human source, the segment is estimated to account major shares in global antithrombin market in 2016. Humans are the major source of antithrombins, but know a day’s the use of goat milk for the production of antithrombin is increasing. Goats produce about 800 liters of milk per year. As compared to cell culture model, the yield of the active protein by goat model is 10 times more. The transgenic goats are the excellent source for antithrombin production, as they produce plenty of milk in short generation time, and these factors are responsible for the high growth of goat milk segment over the forecast period. Currently, the goat milk produced antithrombins are available in developed countries such as U.S., UK, and Germany etc. The increasing adoption of newer technologies and advanced products in developing countries is expected to drive the growth of segment over the forecast period.

On the basis of application, the global antithrombin market is segmented into major three types such as diagnostics, therapeutics, and research. By application, the therapeutics segment is estimated to account major share in global antithrombin market. The increasing research and development activities and rising government initiatives for research are expected to drive the growth of research segment globally.

On the basis of the dosage form, the global antithrombin market is segmented as a liquid and lyophilized. The lyophilized dosage form accounted major share in the global market in 2016 and expected to register high CAGR. Lyophilized antithrombins have good self-life, easy to handle and, have wide application and these factors are expected to propel the growth of segment over the forecast period.

Request Free Sample

Key Market Players & Competitive Landscape

Some of the key players in global Antithrombin market include Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.

Request Free Sample

The global Antithrombin market is segmented as follows:   

By Source

  • Human
  • Goat Milk

By Application

By Dosage Form

  • Liquid
  • Lyophilized

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The global Antithrombin market was valued at USD 543 Million in 2020.

The global Antithrombin market is expected to reach USD 820.8 Million by 2028, growing at a CAGR of 5.3% between 2021 to 2028.

Some of the key factors driving the global Antithrombin market growth are Increasing Number of Surgical Procedures and Technological Advancement.

Europe is anticipated to remain the leading region over the forecast period. The rising adoption of antithrombin therapies owing to high awareness in the region is expected to boost the growth of the market in Europe.

The key dominant player’s operative in global Antithrombin market Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.  

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed